title: The effect of riluzole augmentation in a patient with treatment-resistant obsessive-compulsive disorder, taking two other glutaminergic agents.
authors.forename: Nahla
authors.initials: N
authors.lastname: Mahgoub
authors.forename: Babatunde
authors.initials: B
authors.lastname: Asemota
authors.forename: George S
authors.initials: GS
authors.lastname: Alexopoulos
mesh_terms: D000328:Adult; D002998:Clonazepam / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000627:therapeutic use*; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D018757:GABA Modulators / Q000627:therapeutic use; D006801:Humans; D000077213:Lamotrigine; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D010624:Phenelzine / Q000627:therapeutic use; D019782:Riluzole / Q000627:therapeutic use*; D000077236:Topiramate; D016896:Treatment Outcome; D014227:Triazines / Q000627:therapeutic use
chemical_list: D018691:Excitatory Amino Acid Antagonists; D018757:GABA Modulators; D008996:Monoamine Oxidase Inhibitors; D014227:Triazines; D000077236:Topiramate; D005632:Fructose; D002998:Clonazepam; D019782:Riluzole; D010624:Phenelzine; D000077213:Lamotrigine